Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 97
Inquire Before Buying

Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptoms include bleeding from any site of the body. Internal bleeding is fatal as internal bleeding inside the joint causes joint damage and inside the brain, causes brain damage and seizers. The disease is inherited in an X-linked recessive genetic pattern, therefore males are commonly affected with haemophilia while females are usually carriers of the disease. Haemophilia A is caused by the deficiency of clotting Factor VIII, whereas haemophilia B is caused by the deficiency of Factor IX. It is also known as Christmas disease. The disease management includes factor replacement therapy. Factor replacement therapy is the infusion of factor VIII and IX concentrates through injection to control bleeding. These factor concentrates come from two sources i.e. from human plasma or from genetically engineered cell line made by recombinant DNA technology.

Market Analysis and Insights: Global Hemophilia A and B Recombinant Factor Replacement Therapy Market

The global Hemophilia A and B Recombinant Factor Replacement Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemophilia A and B Recombinant Factor Replacement Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemophilia A and B Recombinant Factor Replacement Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemophilia A and B Recombinant Factor Replacement Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemophilia A and B Recombinant Factor Replacement Therapy market.

Global Hemophilia A and B Recombinant Factor Replacement Therapy Scope and Market Size

Hemophilia A and B Recombinant Factor Replacement Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia A and B Recombinant Factor Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Haemophilia A

- Haemophilia B

Segment by Application

- Hospitals

- Clinics

- AmbulatorySurgicalCenters

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Pfizer

- Novo Nordisk

- Baxalta

- Bayer

- Biogen

- CSL Behring

- Emergent Biosolutions

- Spark therapeutics

- Uniqure

Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Haemophilia A
1.2.3 Haemophilia B
1.3 Market by Application
1.3.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 AmbulatorySurgicalCenters
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Perspective (2016-2027)
2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Growth Trends by Regions
2.2.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Dynamic
2.3.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends
2.3.2 Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers
2.3.3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges
2.3.4 Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue
3.1.1 Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Revenue (2016-2021)
3.1.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue
3.4 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio
3.4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2020
3.5 Hemophilia A and B Recombinant Factor Replacement Therapy Key Players Head office and Area Served
3.6 Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service
3.7 Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Type
4.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Type (2016-2021)
4.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2022-2027)
5 Hemophilia A and B Recombinant Factor Replacement Therapy Breakdown Data by Application
5.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Historic Market Size by Application (2016-2021)
5.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
6.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
6.2.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
6.2.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
6.2.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
6.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
6.3.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
6.3.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
6.3.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
6.4 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
6.4.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
6.4.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
7.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
7.2.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
7.2.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
7.2.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
7.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
7.3.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
7.3.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
7.3.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
7.4 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
7.4.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
7.4.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
8.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
8.2.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
8.3.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region
8.4.1 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
9.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
9.2.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
9.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
9.3.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
9.4 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
9.4.1 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (2016-2027)
10.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type
10.2.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application
10.3.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country
10.4.1 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.1.4 Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.2.4 Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Baxalta
11.3.1 Baxalta Company Details
11.3.2 Baxalta Business Overview
11.3.3 Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.3.4 Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.3.5 Baxalta Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.4.4 Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.5.4 Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.5.5 Biogen Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Details
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.6.4 CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.6.5 CSL Behring Recent Development
11.7 Emergent Biosolutions
11.7.1 Emergent Biosolutions Company Details
11.7.2 Emergent Biosolutions Business Overview
11.7.3 Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.7.4 Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.7.5 Emergent Biosolutions Recent Development
11.8 Spark therapeutics
11.8.1 Spark therapeutics Company Details
11.8.2 Spark therapeutics Business Overview
11.8.3 Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.8.4 Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.8.5 Spark therapeutics Recent Development
11.9 Uniqure
11.9.1 Uniqure Company Details
11.9.2 Uniqure Business Overview
11.9.3 Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Introduction
11.9.4 Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
11.9.5 Uniqure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Haemophilia A
Table 3. Key Players of Haemophilia B
Table 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2016-2021)
Table 8. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2022-2027)
Table 10. Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends
Table 11. Hemophilia A and B Recombinant Factor Replacement Therapy Market Drivers
Table 12. Hemophilia A and B Recombinant Factor Replacement Therapy Market Challenges
Table 13. Hemophilia A and B Recombinant Factor Replacement Therapy Market Restraints
Table 14. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players (2016-2021)
Table 16. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2020)
Table 17. Ranking of Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hemophilia A and B Recombinant Factor Replacement Therapy Product Solution and Service
Table 21. Date of Enter into Hemophilia A and B Recombinant Factor Replacement Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Hemophilia A and B Recombinant Factor Replacement Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 64. Pfizer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novo Nordisk Company Details
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 69. Novo Nordisk Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 70. Novo Nordisk Recent Development
Table 71. Baxalta Company Details
Table 72. Baxalta Business Overview
Table 73. Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 74. Baxalta Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 75. Baxalta Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 79. Bayer Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Biogen Company Details
Table 82. Biogen Business Overview
Table 83. Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 84. Biogen Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 85. Biogen Recent Development
Table 86. CSL Behring Company Details
Table 87. CSL Behring Business Overview
Table 88. CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 89. CSL Behring Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 90. CSL Behring Recent Development
Table 91. Emergent Biosolutions Company Details
Table 92. Emergent Biosolutions Business Overview
Table 93. Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 94. Emergent Biosolutions Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 95. Emergent Biosolutions Recent Development
Table 96. Spark therapeutics Company Details
Table 97. Spark therapeutics Business Overview
Table 98. Spark therapeutics Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 99. Spark therapeutics Recent Development
Table 100. Uniqure Company Details
Table 101. Uniqure Business Overview
Table 102. Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Product
Table 103. Uniqure Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021) & (US$ Million)
Table 104. Uniqure Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type: 2020 VS 2027
Figure 2. Haemophilia A Features
Figure 3. Haemophilia B Features
Figure 4. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. AmbulatorySurgicalCenters Case Studies
Figure 8. Hemophilia A and B Recombinant Factor Replacement Therapy Report Years Considered
Figure 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Regions (2022-2027)
Figure 13. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Players in 2020
Figure 14. Global Top Hemophilia A and B Recombinant Factor Replacement Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A and B Recombinant Factor Replacement Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hemophilia A and B Recombinant Factor Replacement Therapy Revenue in 2020
Figure 16. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 20. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 21. North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 22. United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 26. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 27. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 28. Germany Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Region (2016-2027)
Figure 38. China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hemophilia A and B Recombinant Factor Replacement Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021)
Figure 58. Novo Nordisk Revenue Growth Rate in Hemophilia A and B Recombinant Factor Replacement Therapy Business (2016-2021
  • 2021-2027 Global and Regional Flexible Endoscopes Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Jul-2021        Price: US 3500 Onwards        Pages: 177
    The global Flexible Endoscopes market was valued at 2552.86 Million USD in 2020 and will grow with a CAGR of 9.03% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Eur......
  • 2021-2027 Global and Regional Spinal Cord Stimulation (SCS) Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 23-Jul-2021        Price: US 3500 Onwards        Pages: 144
    The global Spinal Cord Stimulation (SCS) Devices market was valued at 2268.23 Million USD in 2020 and will grow with a CAGR of 6.36% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North Ameri......
  • Global Disposable Blood Lancet Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 145
    Market Analysis and Insights: Global Disposable Blood Lancet Market The global Disposable Blood Lancet market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Disposable Blood Lancet Scope and Market Size The global Disposable Blood Lancet market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Disposable B......
  • Global Medical Uroflowmeter Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 148
    Uroflowmetry is a diagnostic test that is administered to check for abnormalities in the amount or flow rate of a patient's urine. The procedure is straightforward and painless, and simply involves urinating into a funnel device attached to an electronic meter. Doctors commonly use uroflowmetry to check for possible bladder obstructions, kidney problems, prostate enlargement, and urinary tract infections. Unusual test results indicate the need for additional testing procedures, such as x-rays an......
  • Global CO2 Laser Scalpel Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 133
    Market Analysis and Insights: Global CO2 Laser Scalpel Market The global CO2 Laser Scalpel market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global CO2 Laser Scalpel Scope and Market Size The global CO2 Laser Scalpel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CO2 Laser Scalpel market will be abl......
  • Global Surgical Laser Scalpel Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 144
    Market Analysis and Insights: Global Surgical Laser Scalpel Market The global Surgical Laser Scalpel market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Surgical Laser Scalpel Scope and Market Size The global Surgical Laser Scalpel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Laser S......
  • Global Automatic Hematocrit Centrifuges Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 134
    Hematocrit centrifuge is used for determination of volume fractions of erythrocytes (red blood cells) in blood and also for separation of micro blood and solutions. Market Analysis and Insights: Global Automatic Hematocrit Centrifuges Market The global Automatic Hematocrit Centrifuges market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Automatic Hematocrit Centrifuges Scope an......
  • Global Medical Disinfection Robot Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 143
    Medical disinfection robot has the capability to disinfect a whole room in mere minutes, generally using pulsed ultraviolet light. Market Analysis and Insights: Global Medical Disinfection Robot Market The global Medical Disinfection Robot market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Medical Disinfection Robot Scope and Market Size The global Medical Disinfection......
  • Global Disposable Medical Cotton Swabs Sales Market Report 2021
    Published: 22-Jul-2021        Price: US 4000 Onwards        Pages: 138
    Cotton swabs or cotton buds consist of one or two small wads of cotton wrapped around one or both ends of a short rod made of wood, rolled paper or plastic. Market Analysis and Insights: Global Disposable Medical Cotton Swabs Market The global Disposable Medical Cotton Swabs market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. Global Disposable Medical Cotton Swabs Scope and Market Si......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs